BioNexus Gene Lab Corp. (BGLC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.32
-0.04 (-0.75%)
At close: Oct 03, 2025, 3:59 PM
5.29
-0.56%
Pre-market: Oct 06, 2025, 07:20 AM EDT

BioNexus Gene Lab Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.55M 9.27M 9.51M 9.26M 9.18M 9.78M 9.77M 10.34M 10.36M 10.28M 10.93M 11.33M 12.34M 12.94M 13.36M 21.48M 17.93M 14.84M
Cost of Revenue
8.2M 8M 8.24M 8.03M 7.93M 8.47M 8.44M 8.94M 9.01M 9.03M 9.71M 10M 10.61M 11M 11.17M 18M 15.13M 12.52M
Gross Profit
1.35M 1.27M 1.27M 1.23M 1.25M 1.31M 1.33M 1.4M 1.35M 1.25M 1.22M 1.33M 1.72M 1.94M 2.19M 3.47M 2.79M 2.32M
Operating Income
-2.98M -2.11M -1.57M -900.77K -2.09M -2.62M -2.59M -2.97M -510.73K -376.5K -291.18K 32.58K 470.43K 748.38K 1.06M 2.3M 1.87M 1.66M
Interest Income
200.98K 171.21K 176.62K 28.98K 28.98K 28.98K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.9K 2.9K
Pretax Income
-3.01M -2.13M -1.59M -920.29K -2.11M -2.64M -2.61M -2.99M -523.05K -388.1K -303.66K 20.87K 458.65K 735.48K 1.04M 2.28M 1.85M 1.65M
Net Income
-2.93M -2.12M -1.6M -942.61K -2.21M -2.66M -2.63M -3.09M -562.69K -442.1K -355.97K -109.75K 262.97K 429.89K 751.57K 1.93M 1.87M 1.78M
Selling & General & Admin
3.58M 3.21M 3.98M 3.5M 4.45M 4.5M 4.41M 4.91M 2.25M 1.88M 1.69M 1.36M 1.3M 1.25M 1.2M 2.21M 1.92M 1.6M
Research & Development
72.21K 67.85K 55.71K 63.18K 63.18K 54.98K 54.98K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
683.14K 103.3K -995.29K -1.23M -965.77K -227.46K -344.81K -341.52K -197.4K -250.23K -179.28K 6.33K 13.59K 15.99K n/a -1.05M -999.76K -946.42K
Operating Expenses
4.33M 3.38M 3.04M 2.33M 3.55M 4.13M 3.92M 4.38M 1.86M 1.63M 1.51M 1.3M 1.25M 1.2M 1.14M 1.16M 917.05K 644.71K
Interest Expense
21.79K 21.39K 21.15K 19.52K 17.58K 16.14K 13.93K 14.51K 12.32K 11.6K 12.48K 11.7K 11.78K 12.91K 12.94K 8.96K 9.16K 7.09K
Selling & Marketing Expenses
2.1M 1.49M 2.18M 153.87K 153.87K 153.87K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.54M 11.38M 11.08M 10.16M 11.27M 12.4M 12.37M 13.31M 10.87M 10.65M 11.22M 11.3M 11.86M 12.19M 12.31M 19.17M 16.05M 13.17M
Income Tax Expense
-72.16K -16.57K 3.49K 22.32K 97.18K 25.6K 21.53K 105.94K 39.63K 54K 52.31K 130.63K 195.68K 305.58K 291.28K 350.02K 275.34K 167.55K
Shares Outstanding (Basic)
1.8M 1.8M 1.8M 1.8M 1.77M 1.77M 1.77M 1.68M 1.45M 1.45M 1.45M 1.44M 1.43M 1.43M 1.43M 1.43M 1.43M 1.43M
Shares Outstanding (Diluted)
1.8M 1.8M 1.8M 1.8M 1.77M 1.77M 1.77M 1.68M 1.45M 1.45M 1.45M 1.45M 1.44M 1.43M 1.43M 1.43M 1.43M 1.43M
EPS (Basic)
-1.63 -1.18 -0.89 -0.53 -1.34 -1.47 -1.41 -1.59 -0.04 -0.03 -0.02 -0.01 0.02 0.03 0.05 0.03 0.03 0.02
EPS (Diluted)
-1.63 -1.18 -0.89 -0.53 -1.34 -1.47 -1.41 -1.59 -0.04 -0.03 -0.02 -0.01 0.02 0.03 0.05 0.03 0.03 0.02
EBITDA
-2.85M -1.99M -1.42M -761K -1.97M -2.51M -2.49M -2.87M -409.37K -272.86K -185.76K 138.45K 577.29K 868.19K 1.16M 2.45M 2M 1.79M
EBIT
-2.95M -2.08M -1.57M -900.77K -2.09M -2.62M -2.59M -2.97M -510.73K -376.5K -291.18K 32.58K 470.43K 748.38K 1.06M 2.31M 2.18M 2M
Depreciation & Amortization
173.85K 163.58K 153.14K 139.77K 119.99K 113.14K 108.42K 104.82K 101.37K 103.64K 105.42K 105.88K 106.86K 119.81K 108.22K 144.53K 131.06K 103.52K